Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

UNICHEM

  • FDA Approval
  • June 30, 2023, 11:39 UTC
  • 28
  • 0 comments

FDA approve MONTELUKAST SODIUM

Comment Full text

AMNEAL PHARMS

  • FDA Approval
  • June 30, 2023, 11:39 UTC
  • 28
  • 0 comments

FDA approve SPIRONOLACTONE

Comment Full text

UNICHEM

  • FDA Approval
  • June 30, 2023, 11:39 UTC
  • 30
  • 0 comments

FDA approve MONTELUKAST SODIUM

Comment Full text

STRIDES PHARMA

  • FDA Approval
  • June 30, 2023, 11:39 UTC
  • 25
  • 0 comments

FDA approve CLARITHROMYCIN

Comment Full text

JIANGSU HANSOH PHARM

  • FDA Approval
  • June 30, 2023, 11:39 UTC
  • 27
  • 0 comments

FDA approve AZACITIDINE

Comment Full text

CADILA

  • FDA Approval
  • June 30, 2023, 11:39 UTC
  • 29
  • 0 comments

FDA approve LEVOFLOXACIN

Comment Full text

AXSOME MALTA

  • FDA Approval
  • June 30, 2023, 11:39 UTC
  • 30
  • 0 comments

FDA approve SOLRIAMFETOL HYDROCHLORIDE

Comment Full text

SANOFI AVENTIS US

  • FDA Approval
  • June 30, 2023, 11:39 UTC
  • 25
  • 0 comments

FDA approve INSULIN GLARGINE RECOMBINANT

Comment Full text

SANDOZ

  • FDA Approval
  • June 30, 2023, 11:39 UTC
  • 27
  • 0 comments

FDA approve LEVOFLOXACIN

Comment Full text

MICRO LABS

  • FDA Approval
  • June 30, 2023, 11:39 UTC
  • 27
  • 0 comments

FDA approve DOXEPIN HYDROCHLORIDE

Comment Full text
  • Previous
  • 767
  • 768
  • 769
  • 770
  • 771
  • Next

Search

News categories

  • Technical Exchange News(12074)
  • Event(5328)
  • SEC News(250961)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(150288)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin